Birchview Capital as of March 31, 2025
Portfolio Holdings for Birchview Capital
Birchview Capital holds 68 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 36.3 | $42M | 685k | 60.99 | |
| Corcept Therapeutics Incorporated (CORT) | 6.5 | $7.5M | 66k | 114.22 | |
| ACADIA Pharmaceuticals (ACAD) | 3.8 | $4.4M | 263k | 16.61 | |
| Prothena Corp SHS (PRTA) | 3.6 | $4.1M | 333k | 12.38 | |
| Biodesix | 3.1 | $3.6M | 5.7M | 0.63 | |
| Neurocrine Biosciences (NBIX) | 2.9 | $3.3M | 30k | 110.60 | |
| Aziyo Biologics (ELUT) | 2.6 | $3.0M | 1.2M | 2.53 | |
| Axogen (AXGN) | 2.6 | $3.0M | 161k | 18.50 | |
| Phreesia (PHR) | 2.5 | $2.9M | 115k | 25.56 | |
| Travere Therapeutics (TVTX) | 2.1 | $2.5M | 138k | 17.92 | |
| Quidel Corporation | 2.1 | $2.4M | 68k | 34.97 | |
| Protagonist Therapeutics (PTGX) | 2.0 | $2.3M | 48k | 48.36 | |
| United Therapeutics Corporation (UTHR) | 2.0 | $2.3M | 7.5k | 308.27 | |
| Docgo (DCGO) | 2.0 | $2.3M | 864k | 2.64 | |
| Encana Corporation (OVV) | 1.9 | $2.2M | 52k | 42.80 | |
| Harrow Health (HROW) | 1.7 | $1.9M | 73k | 26.60 | |
| Masimo Corporation (MASI) | 1.6 | $1.9M | 11k | 166.60 | |
| EQT Corporation (EQT) | 1.6 | $1.8M | 35k | 53.43 | |
| Castle Biosciences (CSTL) | 1.5 | $1.8M | 88k | 20.02 | |
| Alkermes SHS (ALKS) | 1.4 | $1.7M | 50k | 33.02 | |
| Stoke Therapeutics (STOK) | 1.2 | $1.4M | 210k | 6.65 | |
| Treace Med Concepts (TMCI) | 1.2 | $1.4M | 165k | 8.39 | |
| Foghorn Therapeutics (FHTX) | 1.0 | $1.1M | 311k | 3.65 | |
| Uniqure Nv SHS (QURE) | 0.8 | $940k | 89k | 10.60 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $773k | 67k | 11.54 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $705k | 21k | 33.55 | |
| Axsome Therapeutics (AXSM) | 0.6 | $700k | 6.0k | 116.63 | |
| Kiniksa Pharmaceuticals | 0.6 | $666k | 30k | 22.21 | |
| Halozyme Therapeutics (HALO) | 0.6 | $638k | 10k | 63.81 | |
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $579k | 16k | 36.21 | |
| Novocure Ord Shs (NVCR) | 0.5 | $552k | 31k | 17.82 | |
| Scholar Rock Hldg Corp (SRRK) | 0.4 | $514k | 16k | 32.15 | |
| Orthopediatrics Corp. (KIDS) | 0.4 | $493k | 20k | 24.63 | |
| Solid Biosciences Com New (SLDB) | 0.4 | $476k | 129k | 3.70 | |
| Inhibrx Biosciences (INBX) | 0.4 | $449k | 32k | 13.99 | |
| 10x Genomics Cl A Com (TXG) | 0.4 | $437k | 50k | 8.73 | |
| Cytokinetics (CYTK) | 0.3 | $402k | 10k | 40.19 | |
| Springworks Therapeutics (SWTX) | 0.3 | $365k | 8.3k | 44.13 | |
| Pulmonx Corp (LUNG) | 0.3 | $343k | 51k | 6.73 | |
| Candel Therapeutics (CADL) | 0.3 | $339k | 60k | 5.65 | |
| Alphatec Holdings (ATEC) | 0.3 | $335k | 33k | 10.14 | |
| Wave Life Sciences SHS (WVE) | 0.3 | $326k | 40k | 8.08 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.3 | $313k | 8.0k | 39.07 | |
| Apellis Pharmaceuticals (APLS) | 0.3 | $306k | 14k | 21.87 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $300k | 40k | 7.50 | |
| Apogee Therapeutics (APGE) | 0.3 | $299k | 8.0k | 37.36 | |
| Xencor (XNCR) | 0.2 | $277k | 26k | 10.64 | |
| Outset Med | 0.2 | $272k | 25k | 11.06 | |
| Blueprint Medicines (BPMC) | 0.2 | $239k | 2.7k | 88.51 | |
| Amicus Therapeutics (FOLD) | 0.2 | $229k | 28k | 8.16 | |
| Accelr8 Technology | 0.2 | $228k | 325k | 0.70 | |
| Arvinas Ord (ARVN) | 0.2 | $211k | 30k | 7.02 | |
| Neuropace (NPCE) | 0.2 | $202k | 16k | 12.29 | |
| Tela Bio (TELA) | 0.2 | $189k | 155k | 1.22 | |
| Keros Therapeutics (KROS) | 0.1 | $153k | 15k | 10.19 | |
| Gossamer Bio (GOSS) | 0.1 | $152k | 138k | 1.10 | |
| Cullinan Oncology (CGEM) | 0.1 | $151k | 20k | 7.57 | |
| Liquidia Technologies (LQDA) | 0.1 | $148k | 10k | 14.75 | |
| Direxion Daily Pharmaceutical & Medical Bull 3x Sh Dly Tech Bull 3x (TECL) | 0.1 | $144k | 20k | 7.22 | |
| Atara Biotherapeutics Com New (ATRA) | 0.1 | $131k | 22k | 5.94 | |
| Zenas Biopharma (ZBIO) | 0.1 | $130k | 17k | 7.90 | |
| Karyopharm Therapeutics | 0.1 | $105k | 28k | 3.74 | |
| 2seventy Bio | 0.1 | $77k | 16k | 4.94 | |
| Alumis (ALMS) | 0.1 | $61k | 10k | 6.14 | |
| Inflarx Nv (IFRX) | 0.0 | $51k | 50k | 1.02 | |
| Compass Therapeutics (CMPX) | 0.0 | $46k | 24k | 1.90 | |
| Ventyx Biosciences (VTYX) | 0.0 | $33k | 29k | 1.15 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.0 | $27k | 17k | 1.59 |